Optimal contouring of seminal vesicle for definitive radiotherapy of localized prostate cancer: comparison between EORTC prostate cancer radiotherapy guideline, RTOG0815 protocol and actual anatomy

Radiation Oncology

Dian Wang⁴  Fei-Yu Li³  Bo Zhao¹  Ming-Wei Ma¹  Hong-Zhen Li¹  Min Zhang¹  Junichi Asaumi²  Xian-Shu Gao¹  Xin Qi¹ 

[1] Department of Radiation Oncology, Peking University First Hospital, Beijing, China;Department of Oral and Maxillofacial Radiology, Field of Tumor Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;Department of Radiology, Peking University First Hospital, Beijing, China;Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, USA

关键词: CT reconstruction;    Target delineation;    Seminal vesicle;    Radiotherapy;    Prostate cancer;   

Others  :  1150431
DOI  :  10.1186/s13014-014-0288-1

 received in 2014-05-08, accepted in 2014-12-04,  发布年份 2014

【 摘 要 】

Background

Intermediate- to-high-risk prostate cancer can locally invade seminal vesicle (SV). It is recommended that anatomic proximal 1-cm to 2-cm SV be included in the clinical target volume (CTV) for definitive radiotherapy based on pathology studies. However, it remains unclear whether the pathology indicated SV extent is included into the CTV defined by current guidelines. The purpose of this study is to compare the volume of proximal SV included in CTV defined by EORTC prostate cancer radiotherapy guideline and RTOG0815 protocol with the actual anatomic volume.

Methods

Radiotherapy planning CT images from 114 patients with intermediate- (36.8%) or high-risk (63.2%) prostate cancer were reconstructed with 1-mm-thick sections. The starting and ending points of SV and the cross sections of SV at 1-cm and 2-cm from the starting point were determined using 3D-view. Maximum (D_1H, D_2H) and minimum (D_1L, D_2L) vertical distance from these cross sections to the starting point were measured. Then, CTV of proximal SV defined by actual anatomy, EORTC guideline and RTOG0815 protocol were contoured and compared (paired t test).

Results

Median length of D_1H, D_1L, D_2H and D_2L was 10.8 mm, 2.1 mm, 17.6 mm and 8.8 mm (95th percentile: 13.5mm, 5.0mm, 21.5mm and 13.5mm, respectively). For intermediate-risk patients, the proximal 1-cm SV CTV defined by EORTC guideline and RTOG0815 protocol inadequately included the anatomic proximal 1-cm SV in 62.3% (71/114) and 71.0% (81/114) cases, respectively. While for high-risk patients, the proximal 2-cm SV CTV defined by EORTC guideline inadequately included the anatomic proximal 2-cm SV in 17.5% (20/114) cases.

Conclusions

SV involvement indicated by pathology studies was not completely included in the CTV defined by current guidelines. Delineation of proximal 1.4 cm and 2.2 cm SV in axial plane may be adequate to include the anatomic proximal 1-cm and 2-cm SV. However, part of SV may be over-contoured.

【 授权许可】

   
2014 Qi et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Eifler JB, Feng Z, Lin BM, Partin MT, Humphreys EB, Han M, Epstein JI, Walsh PC, Trock BJ, Partin AW: An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011. BJU Int 2013, 111:22-29.
• [2]Katcher J, Kupelian PA, Zippe C, Klein EA, Sohn JW: Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 1997, 37:871-876.
• [3]D'amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A, Coleman CN: Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV. Int J Radiat Oncol Biol Phys 1997, 39:335-340.
• [4]Zlotta AR, Roumeguère T, Ravery V, Hoffmann P, Montorsi F, Türkeri L, Dobrovrits M, Scattoni V, Ekane S, Bollens R: Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients. Eur Urol 2004, 46:42-49.
• [5]Villers AA, McNeal JE, Redwine EA, Freiha FS, Stamey TA: Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J Urol 1990, 143:1183-1187.
• [6]Kestin L, Goldstein N, Vicini F, Yan D, Korman H, Martinez A: Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume? Int J Radiat Oncol Biol Phys 2002, 54:686-697.
• [7]Epstein JI, Partin AW, Potter SR, Walsh PC: Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urology 2000, 56:283-288.
• [8]Korman HJ, Watson RB, Civantos F, Block NL, Soloway MS: Radical prostatectomy: is complete resection of the seminal vesicles really necessary? J Urol 1996, 156:1081-1083.
• [9]Boehmer D, Maingon P, Poortmans P, Baron MH, Miralbell R, Remouchamps V, Scrase C, Bossi A, Bolla M: Guidelines for primary radiotherapy of patients with prostate cancer. Radiother Oncol 2006, 79:259-269.
• [10]Swanson GP, Goldman B, Tangen CM, Chin J, Messing E, Canby-Hagino E, Forman JD, Thompson IM, Crawford ED: The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794. J Urol 2008, 180:2453-2457. discussion 2458
• [11]Meeks JJ, Walker M, Bernstein M, Eastham JA: Seminal vesicle involvement at salvage radical prostatectomy. BJU Int 2013, 111:E342-E347.
• [12]Bayman NA, Wylie JP: When should the seminal vesicles be included in the target volume in prostate radiotherapy? Clin Oncol (R Coll Radiol) 2007, 19:302-307.